REDUCEDT+7
Artiva Biotherapeutics Inc · NASDAQ
−8,370 sh · $57.2K
Filed 6 Oct 2026SEC Form 4view source
- ACQUIREDStale
Artiva Biotherapeutics Inc · NASDAQ
+45,000 sh
Filed 11 Sept 2026SEC Form 4view source - REDUCEDStale
Artiva Biotherapeutics Inc · NASDAQ
−8,391 sh · $93.6K
Filed 4 Sept 2026SEC Form 4view source